Mesenchymal –epithelial transition gene amplification and protein overexpression in stage IV pulmonary adenocarcinoma
ConclusionsAlthoughMET amplification-positive tumor is considered aggressive, our results suggest that it has a more favorable prognosis than amplification-negative cases in stage IV pulmonary adenocarcinoma with medical treatment.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Genetics | Immunotherapy | Japan Health | Lung Cancer | Non-Small Cell Lung Cancer | Palliative | Palliative Care | Statistics